32.2003.19% ( -1.060 )
Delay Closed: Nov 17, 16:08:15Financials
Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: LEADS BIOLABS-B(09887) the Revenue is 20.77 M (--%);the EBIT is -113.44 M (-13.75%);the EPS is -0.651 (-2.07%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.02B--
----
----
EBIT
-0.11B13.75%
----
----
EPS
-0.65052.07%
----
----
Upcoming earnings report - FY2026 Q3 Earning Release
Available dateDec 1, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--
Revenue
ActualEstimateUnit: HKD
Quarterly
EBIT
ActualEstimateUnit: HKD
Quarterly
Net income
ActualEstimateUnit: HKD
Quarterly
EPS
ActualEstimateUnit: HKD
Quarterly
